CME Credit available based on ARCC funded study in The Oncologist

/0 Comments/in /by
We are proud to announce that an ARCC funded study led by Dr. Sonya Cressman and published in The Oncologist has been selected as a CME offering. Their article titled: “A time-trend economic analysis of cancer drug trials” is available for a Maximum of 1 credit unit course. The target (more…)
The Canadian Centre for Applied Research in Cancer Control

Changes to ARCC Research Programs

/0 Comments/in /by
**This message is sent on behalf of Dr. Stuart Peacock and Dr. Kelvin Chan – ARCC Co-Directors** ARCC is entering an exciting time as the Centre continues to grow and develop new opportunities in its second five year term. In the coming weeks we will be letting you know more (more…)

ICES Live Chat on End-of-Life Cancer Care

/0 Comments/in /by
Join ICES for a live twitter discussion on end-of-life cancer care quality indicators in Canada! During this Twitter chat, ICES will discuss, “Quality indicators of end-of-life care in patients with cancer: what rate is right?”, a recent ICES study funded by the Canadian Centre for Applied Research in Cancer Control and (more…)

ARCC and McMaster Health Forum awarded CPAC grant

/0 Comments/in /by
Drug expenditures in oncology have risen faster than in other areas of health care. While health gains have been made in the treatment of cancer with new therapies, there is concern among policy makers and health care providers that the high costs for new cancer treatments might not be justified (more…)

ARCC Investigator Lisa Barbera’s work makes the Top 10 CCS-Funded Research Stories of 2015

/0 Comments/in /by
Today, January 4th 2015, the Canadian Cancer Society has published their Top 10 CCS-Funded Research Stories for 2015: click here for details. ARCC is very proud to announce that one of our ARCC Investigators, Dr. Lisa Barbera has been featured this year for her May 2015 Publication in the Journal of (more…)

Change in ARCC Co-Directorship effective December 1, 2015

/0 Comments/in /by
Thank you Dr. Jeffrey Hoch In November 2015, Dr. Jeffrey Hoch stepped down from his role as Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC). Dr. Hoch is an original ARCC Co-Founder, and has helped lead ARCC since 2009. During that time the ARCC Network has (more…)

CADTH Regognition Awards – Nominations Being Accepted

/0 Comments/in , /by
            Nominations are now being accepted for two prestigious awards for outstanding achievement in the field of health technology assessment (HTA) in Canada. Do you know someone who has been a leader and champion of health technology assessment (HTA) over many years, or perhaps a (more…)

An Introduction to the Cancer Risk Management Model (CRMM) – Webinar

/0 Comments/in , /by
TO REGISTER FOR THIS WEBINAR: Contact Saima – saima.memon@partnershipagainstcancer.ca The Data Use and Publications Committee (DUPC), a subcommittee of the Canadian Council of Cancer Registries, in partnership with the Canadian Partnership Against Cancer (CPAC), is pleased to announce an upcoming webinar focusing on CPAC’s Cancer Risk Management Model (CRMM) on (more…)

CADTH Drug Portfolio Information Sessions – October 14th, 2015

/0 Comments/in , /by
The CADTH Drug Portfolio Information Sessions are an opportunity to receive an update on CADTH’s Drug Portfolio, including the Common Drug Review (CDR), the pan-Canadian Oncology Drug Review (pCODR), Therapeutic Reviews, and the Rapid Response program. CADTH’s Patient Engagement Strategy, Scientific Advice Program, and the alignment of CDR and pCODR (more…)